Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma

Benedito A. Carneiro, Kyriakos P. Papadopoulos, John H. Strickler, Andrew B. Lassman, Saiama N. Waqar, Young Kwang Chae, Jyoti D. Patel, Einat Shacham-Shmueli, Karen Kelly, Mustafa Khasraw, Christine M. Bestvina, Ryan Merrell, Kevin Huang, Harisha Atluri, Peter Ansell, Rachel Li, Janet Jin, Mark G. Anderson, Edward B. Reilly, Gladys Morrison-ThieleKalpesh Patel, Randy R. Robinson, Martha R.Neagu Aristide, Hui K. Gan

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences